0000939767-17-000079.txt : 20170510 0000939767-17-000079.hdr.sgml : 20170510 20170510200746 ACCESSION NUMBER: 0000939767-17-000079 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170508 FILED AS OF DATE: 20170510 DATE AS OF CHANGE: 20170510 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXELIXIS, INC. CENTRAL INDEX KEY: 0000939767 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043257395 STATE OF INCORPORATION: DE FISCAL YEAR END: 0102 BUSINESS ADDRESS: STREET 1: 210 E. GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508377000 MAIL ADDRESS: STREET 1: 210 E. GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS INC DATE OF NAME CHANGE: 20000207 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MORRISSEY MICHAEL CENTRAL INDEX KEY: 0001202096 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30235 FILM NUMBER: 17832042 MAIL ADDRESS: STREET 1: C/O EXELIXIS INC STREET 2: 170 HARBOR WAY CITY: SAN FRANCISCO STATE: CA ZIP: 94083 FORMER NAME: FORMER CONFORMED NAME: MORRISSEY MICHAEL M DATE OF NAME CHANGE: 20030512 FORMER NAME: FORMER CONFORMED NAME: MORRISSEY MICHAEL R DATE OF NAME CHANGE: 20021029 4 1 wf-form4_149446125113476.xml FORM 4 X0306 4 2017-05-08 0 0000939767 EXELIXIS, INC. EXEL 0001202096 MORRISSEY MICHAEL C/O EXELIXIS, INC. 210 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 1 1 0 0 President and CEO Common Stock 2017-05-08 4 M 0 11300 1.90 A 71300 D Common Stock 2017-05-08 4 S 0 11300 21.81 D 60000 D Common Stock 2017-05-09 4 M 0 51214 1.90 A 111214 D Common Stock 2017-05-09 4 S 0 51214 21.77 D 60000 D Common Stock 2017-05-09 4 M 0 48786 1.90 A 108786 D Common Stock 2017-05-09 4 S 0 48786 21.60 D 60000 D Common Stock 2017-05-10 4 M 0 79551 1.90 A 139551 D Common Stock 2017-05-10 4 M 0 20449 1.70 A 160000 D Common Stock 2017-05-10 4 S 0 100000 22.07 D 60000 D Common Stock 172698 I By Trust Common Stock 17018 I By 401(k) Option (right to buy) 1.9 2017-05-08 4 M 0 11300 0 D 2015-07-20 2022-02-04 Common Stock 11300.0 179551 D Option (right to buy) 1.9 2017-05-09 4 M 0 51214 0 D 2015-07-20 2022-02-04 Common Stock 51214.0 128337 D Option (right to buy) 1.9 2017-05-09 4 M 0 48786 0 D 2015-07-20 2022-02-04 Common Stock 48786.0 79551 D Option (right to buy) 1.9 2017-05-10 4 M 0 79551 0 D 2015-07-20 2022-02-04 Common Stock 79551.0 0 D Option (right to buy) 1.7 2017-05-10 4 M 0 20449 0 D 2015-07-20 2021-09-18 Common Stock 20449.0 1104551 D Includes 60,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.80 to $21.84. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.75 to $21.80. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.60 to $21.61. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.00 to $22.15. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 5 to this Form 4. Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Represents 17,018 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 8, 2017. The option, representing the right to purchase a total of 450,000 shares of Exelixis, Inc. common stock, became exercisable as to fifty percent (50%) of the shares subject to the option on July 20, 2015, as to twenty-five (25%) of the shares subject to the option on March 7, 2016 and as to the remaining twenty-five (25%) of the shares subject to the option on April 28, 2016. The option, representing the right to purchase a total of 1,125,000 shares of Exelixis, Inc. common stock, became exercisable as to fifty percent (50%) of the shares subject to the option on July 20, 2015, as to twenty-five (25%) of the shares subject to the option on March 7, 2016 and as to the remaining twenty-five (25%) of the shares subject to the option on April 28, 2016. /s/ Jeffrey J. Hessekiel, Attorney in Fact 2017-05-10